What is AKSM?
AKSM is a specialized entity in the healthcare sector, focusing on Extracorporeal Shock Wave Lithotripsy (ESWL) for kidney stone treatment. The company distinguishes itself through its leadership in integrating Intensity-Modulated Radiation Therapy (IMRT) and Image-Guided Radiation Therapy (IGRT) into urology practices. A core tenet of AKSM's philosophy is the emphasis on integrated urology care, driven by physician ownership. Their offerings are designed for urology practices and healthcare providers seeking to elevate patient care standards. AKSM also actively supports its initiatives by providing valuable resources, including informational brochures and white papers, to stakeholders.
How much funding has AKSM raised?
AKSM has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in AKSM
PPP
Public-Private Partnership
What's next for AKSM?
The recent major strategic investment, coupled with the overall enterprise-level funding context, suggests AKSM is poised for significant scaling and innovation. This capital infusion is likely to accelerate the adoption of their advanced urological technologies and integrated care models. Future developments may include expanding their service reach, further enhancing their technological platforms, and potentially forging new partnerships within the healthcare ecosystem to solidify their leadership in urology practice enhancement.
See full AKSM company page
